Novartis, Propeller Health co-package new asthma treatment
https://www.mobihealthnews.com/news/novartis-propeller-health-co-package-new-asthma-treatment
Novartis and respiratory health company Propeller Health, a ResMed subsidiary, have teamed up to co-package the latter’s digital health platform with the pharma giant’s new asthma medication Enerzair Breezhaler.
This news come shortly after the product landed European Commission clearance. The co-packaged product will be launching in the EU during 2020.